Analysis of The Cancer Genome Atlas (TCGA) data verified that the BLM-treated signature correlated with MHC-I expression in human cancers, showing a positive correlation across numerous cancer types with gene signatures of the MHC-I pathway (Supplemental Figure 2F). This evidence concerns the gene BLM and cancer.